These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


84 related items for PubMed ID: 462170

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
    Tran TH, Marbet GA, Duckert F.
    Thromb Haemost; 1981 Dec 23; 46(4):699-705. PubMed ID: 6800051
    [Abstract] [Full Text] [Related]

  • 3. The subunit structure of normal and hemophilic factor VIII.
    Shapiro GA, Andersen JC, Pizzo SV, McKee PA.
    J Clin Invest; 1973 Sep 23; 52(9):2198-210. PubMed ID: 4199414
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies].
    Tanaka I, Yoshioka A, Shima M, Fujiwara T, Terada S, Nakai H, Miyata S, Sawamoto Y, Kamisue S, Fukui H.
    Rinsho Ketsueki; 1989 Jul 23; 30(7):951-7. PubMed ID: 2509762
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME, McKee PA.
    J Clin Invest; 1976 Apr 23; 57(4):925-37. PubMed ID: 1084890
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The immunological properties of factor VIII. I. Studies on the inhibitory activity of specific antisera to human antihemophilic globulin.
    Uszyński L.
    Thromb Diath Haemorrh; 1966 Dec 01; 16(3):558-73. PubMed ID: 5301276
    [No Abstract] [Full Text] [Related]

  • 11. Mechanism of factor VIII inactivation by human antibodies. IV. Antibody binding prevents factor VIII proteolysis by thrombin.
    Lazarchick J, Ashby MA, Lazarchick JJ, Sens DA.
    Ann Clin Lab Sci; 1986 Dec 01; 16(6):497-501. PubMed ID: 3099625
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The stability of factor VIII in heparinized plasma.
    Krachmalnicoff A, Thomas DP.
    Thromb Haemost; 1983 Jun 28; 49(3):224-7. PubMed ID: 6410534
    [Abstract] [Full Text] [Related]

  • 14. The influence of thrombin on the platelet-aggregating activity of human factor VIII. A study with insolubilized thrombin.
    Vukovich T, Koller E, Doleschel W.
    Thromb Haemost; 1979 Oct 31; 42(3):832-7. PubMed ID: 505400
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanism of factor VIII inactivation by human antibodies. III. Proteolytic cleavage of factor VIII:C and C antigen by thrombin.
    Lazarchick J, Ashby MA, Lazarchick JJ, Sens DA.
    Ann Clin Lab Sci; 1985 Oct 31; 15(6):482-7. PubMed ID: 3933404
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Changes in polypeptide-specific factor VIII antigen levels during whole blood clotting.
    Tanaka I, Yoshioka A, Shima M, Fujiwara T, Terada S, Nakai H, Sawamoto Y, Kamisue S, Fukui H.
    Int J Hematol; 1991 Dec 31; 54(6):523-30. PubMed ID: 1724392
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.